Cargando…

Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies

Detalles Bibliográficos
Autores principales:	Liu, Bingfeng, Shi, Yaling, Zhang, Wanying, Li, Rong, He, Zhangping, Yang, Xiaofan, Pan, Yuejun, Deng, Xilong, Tan, Mingkai, Zhao, Lingzhai, Zou, Fan, Zhang, Yiwen, Pan, Ting, Zhang, Junsong, Zhang, Xu, Xiao, Fei, Li, Fang, Deng, Kai, Zhang, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493297/ https://www.ncbi.nlm.nih.gov/pubmed/32939033 http://dx.doi.org/10.1038/s41423-020-00528-0

Ejemplares similares

Pam2CSK4-adjuvanted SARS-CoV-2 RBD nanoparticle vaccine induces robust humoral and cellular immune responses
por: Qiao, Yidan, et al.
Publicado: (2022)

Host factor SMYD3 is recruited by Ebola virus nucleoprotein to facilitate viral mRNA transcription
por: Chen, Jingliang, et al.
Publicado: (2019)

A potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBD
por: Wang, Xiaofei, et al.
Publicado: (2022)

Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
por: Ma, Xiancai, et al.
Publicado: (2020)

Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China
por: Tan, Mingkai, et al.
Publicado: (2020)

SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance
por: Zhang, Xiantao, et al.
Publicado: (2021)

Development of Receptor Binding Domain (RBD)‐Conjugated Nanoparticle Vaccines with Broad Neutralization against SARS‐CoV‐2 Delta and Other Variants
por: Chen, Ran, et al.
Publicado: (2022)

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
por: Tai, Wanbo, et al.
Publicado: (2020)

Longitudinal kinetics of RBD+ antibodies in COVID-19 recovered patients over 14 months
por: Eyran, Tsuf, et al.
Publicado: (2022)

Two waves of pro-inflammatory factors are released during the influenza A virus (IAV)-driven pulmonary immunopathogenesis
por: Zhang, Junsong, et al.
Publicado: (2020)

Probable RBD Associates with the Development of RLS in Parkinson's Disease: A Cross-Sectional Study
por: Qu, Yewei, et al.
Publicado: (2019)

Preferential Homing of Tumor-specific and Functional CD8(+) Stem Cell-like Memory T Cells to the Bone Marrow
por: Wu, Kang, et al.
Publicado: (2019)

TRIM28 promotes HIV-1 latency by SUMOylating CDK9 and inhibiting P-TEFb
por: Ma, Xiancai, et al.
Publicado: (2019)

Gemykibivirus Genome in Lower Respiratory Tract of Elderly Woman With Unexplained Acute Respiratory Distress Syndrome
por: Wang, Jian, et al.
Publicado: (2019)

Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity
por: Chen, Weilie, et al.
Publicado: (2020)

Author Correction: Temporal dynamics in viral shedding and transmissibility of COVID-19
por: He, Xi, et al.
Publicado: (2020)

Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

Hyposmia Is Associated with RBD for PD Patients with Variants of SNCA
por: Li, Yuanyuan, et al.
Publicado: (2017)

Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19
por: Chen, Xiangyu, et al.
Publicado: (2020)

A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2
por: Yuan, Yaochang, et al.
Publicado: (2022)

Author Correction: Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

Liquid Metal-Based Flexible Bioelectrodes for Management of In-Stent-Restenosis: Potential Application
por: Zhang, Xilong, et al.
Publicado: (2023)

SARS-CoV-2 tetrameric RBD protein blocks viral infection and induces potent neutralizing antibody response
por: Liu, Zheng, et al.
Publicado: (2022)

Antibody response and cross-neutralization after Omicron BA.2 infection
por: Zhang, Yiwen, et al.
Publicado: (2023)

Small molecule therapeutics to destabilize the ACE2-RBD complex: A molecular dynamics study
por: Razizadeh, Meghdad, et al.
Publicado: (2021)

2356. Close correlation of RBD with Live Viral Neutralising Capacity Across Variants and Time Supports Use of RBD Thresholds to Predict Protective Host Immunity
por: Kenny, Grace, et al.
Publicado: (2023)

Lovastatin Inhibits HIV-1-Induced MHC-I Downregulation by Targeting Nef–AP-1 Complex Formation: A New Strategy to Boost Immune Eradication of HIV-1 Infected Cells
por: Liu, Bingfeng, et al.
Publicado: (2019)

HBD-2 binds SARS-CoV-2 RBD and blocks viral entry: Strategy to combat COVID-19
por: Zhang, Liqun, et al.
Publicado: (2022)

Identification of CD98 as a Novel Biomarker for HIV-1 Permissiveness and Latent Infection
por: Zhang, Wanying, et al.
Publicado: (2022)

Glycopeptide Antibiotic Teicoplanin Inhibits Cell Entry of SARS-CoV-2 by Suppressing the Proteolytic Activity of Cathepsin L
por: Yu, Fei, et al.
Publicado: (2022)

Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants
por: Wu, Yan, et al.
Publicado: (2023)

The CD39(+) HBV surface protein-targeted CAR-T and personalized tumor-reactive CD8(+) T cells exhibit potent anti-HCC activity
por: Zou, Fan, et al.
Publicado: (2021)

Small Molecules to Destabilize the ACE2-RBD Complex: A Molecular Dynamics Study for Potential COVID-19 Therapeutics
por: Razizadeh, Meghdad, et al.
Publicado: (2020)

Editorial: The role of inflammasome in viral infection
por: Wan, Pin, et al.
Publicado: (2023)

Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates
por: Zhao, Hui, et al.
Publicado: (2021)

A SARS-CoV-2 nanobody that can bind to the RBD region may be used for treatment in COVID-19 in animals
por: Wu, Peng, et al.
Publicado: (2022)

The complete chloroplast genome of Callicarpa integerrima var. chinensis (Lamiaceae) from Guilin, China, a potential medicinal plant
por: Gu, Chunjiao, et al.
Publicado: (2021)

Significantly reduced abilities to cross-neutralize SARS-CoV-2 variants by sera from convalescent COVID-19 patients infected by Delta or early strains
por: Pan, Ting, et al.
Publicado: (2021)

Effects of whole-body vibration training on lower limb motor function and neural plasticity in patients with stroke: protocol for a randomised controlled clinical trial
por: Zhang, Mingkai, et al.
Publicado: (2022)

Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56
por: Zou, Fan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d98h9obtv19bjepv6iqcphe6h4